Abstract
Chromatographic studies and microbiological assays show that, after oral administration, cephaloglycin is partially converted in man to a biologically active metabolite desacetylcephaloglycin. The antibacterial activity of this metabolite compared to that of cephaloglycin is equivalent against gram-positive organisms but is lower against gram-negative bacilli. Successful therapy of urinary tract infections with cephaloglycin must be mainly attributed to the antibacterial activity of this metabolite. At the present time, it is not possible to assess what influence low amounts of unaltered cephaloglycin have on the outcome of therapy.
Full text
PDF








Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BONIECE W. S., WICK W. E., HOLMES D. H., REDMAN C. E. In vitro and in vivo laboratory evaluation of cephalothin, a new broad spectrum antibiotic. J Bacteriol. 1962 Dec;84:1292–1296. doi: 10.1128/jb.84.6.1292-1296.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
- Boyer J. L., Andriole V. T. Laboratory and clinical studies of a new antibiotic, cephaloglycin in the treatment of urinary tract infections. Yale J Biol Med. 1968 Feb;40(4):284–295. [PMC free article] [PubMed] [Google Scholar]
- Hoehn M. M., Pugh C. T. Method for the detection and quantitative assay of cephaloglycin and its biologically active metabolites. Appl Microbiol. 1968 Aug;16(8):1132–1133. doi: 10.1128/am.16.8.1132-1133.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hogan L. B., Jr, Holloway W. J., Jakubowitch R. A. Clinical experience with cephaloglycin. Antimicrob Agents Chemother (Bethesda) 1967;7:624–629. [PubMed] [Google Scholar]
- Kukolja S. Chemistry of cephalosporin antibiotics. XI. Preparation and properties of desacetylcephaloglycin and its lactone. J Med Chem. 1968 Sep;11(5):1067–1069. doi: 10.1021/jm00311a035. [DOI] [PubMed] [Google Scholar]
- LEE C. C., HERR E. B., Jr, ANDERSON R. C. Pharmacological and toxicological studies on cephalotin. Clin Med (Northfield) 1963 Jun;70:1123–1138. [PubMed] [Google Scholar]
- Ronald A. R., Turck M. Factors influencing in vitro susceptibility to the cephalosporins and clinical trial of an oral cephalosporin, cephaloglycin. Antimicrob Agents Chemother (Bethesda) 1966;6:82–87. [PubMed] [Google Scholar]
- Shimizu K., Nishimura H. Problems in the bio-assay of orally administered cephaloglycin in biological fluids and method for the detection of its metabolite, desacetylcephaloglycin. J Antibiot (Tokyo) 1970 Apr;23(4):216–222. doi: 10.7164/antibiotics.23.216. [DOI] [PubMed] [Google Scholar]
- WICK W. E., BONIECE W. S. IN VITRO AND IN VIVO LABORATORY EVALUATION OF CEPHALOGLYCIN AND CEPHALORIDINE. Appl Microbiol. 1965 Mar;13:248–253. doi: 10.1128/am.13.2.248-253.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WICK W. E., STREIGHTOFF F., HOLMES D. H. Guide to antibiotic therapy of experimental bacterial infections in mice. J Bacteriol. 1961 Feb;81:233–235. doi: 10.1128/jb.81.2.233-235.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wick W. E. Delineation of the differences of various bacterial susceptibility tests with cephalexin. Antimicrob Agents Chemother (Bethesda) 1968;8:435–441. [PubMed] [Google Scholar]
- Wick W. E. In vitro and in vivo laboratory comparison of cephalothin and desacetylcephalothin. Antimicrob Agents Chemother (Bethesda) 1965;5:870–875. [PubMed] [Google Scholar]